ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

22,220Medicare Part D Prescriptions Filled, Including Refills

Rank: 7 out of 944

$1.05M Total Retail Price of All Prescriptions

Rank: 14 out of 944

717 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
42% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Wisconsin
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 717 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

13% of this provider’s 717 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 20,701 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Wisconsin
WARFARIN SODIUM 972 929 1 7
FUROSEMIDE 910 865 2 6
LISINOPRIL 845 774 3 3
SIMVASTATIN 813 704 4 1
LEVOTHYROXINE SODIUM 725 662 5 2
OMEPRAZOLE 670 628 6 4
METOPROLOL TARTRATE 504 500 7 8
AMLODIPINE BESYLATE 497 472 8 5
POTASSIUM CHLORIDE 476 466 9 15
CITALOPRAM HBR 445 431 10 19
ALENDRONATE SODIUM 394 380 11 20
HYDROCHLOROTHIAZIDE 393 375 12 9
DONEPEZIL HCL 346 346 13 24
METOPROLOL SUCCINATE 324 308 14 14
MIRTAZAPINE 315 311 15 35
ATENOLOL 293 274 16 11
NAMENDA 273 271 17 37
METFORMIN HCL 266 240 18 12
ISOSORBIDE MONONITRATE ER 259 258 19 52
HYDROCODONE-ACETAMINOPHEN 251 220 S3 20 10
PRAVASTATIN SODIUM 247 225 21 17
DIGOXIN 246 234 22 39
CLOPIDOGREL 241 237 23 36
LIDODERM 235 233 24 73
TRAMADOL HCL 227 224 25 21
POLYETHYLENE GLYCOL 3350 221 215 26 41
LOVASTATIN 209 189 27 26
ATORVASTATIN CALCIUM 198 195 28 13
TAMSULOSIN HCL 196 190 29 27
KLOR-CON M10 193 193 30 122
PREDNISONE 190 173 31 32
ENALAPRIL MALEATE 186 181 32 43
PLAVIX 172 168 33 55
LANTUS 171 140 34 46
CARVEDILOL 169 169 35 30
DOXAZOSIN MESYLATE 165 143 36 60
ALLOPURINOL 155 121 37 22
GABAPENTIN 148 132 38 18
PANTOPRAZOLE SODIUM 136 124 39 34
KLOR-CON M20 133 131 40 71
CARBIDOPA-LEVODOPA 131 131 41 77
CLOTRIMAZOLE-BETAMETHASONE 131 128 41 179
FENTANYL 123 113 S2 43 57
FAMOTIDINE 120 115 44 74
HUMULIN R 117 117 45 242
ZOLPIDEM TARTRATE 107 86 46 25
SPIRONOLACTONE 106 91 47 44
SERTRALINE HCL 105 103 48 23
GLIPIZIDE 104 104 49 51
FLUTICASONE PROPIONATE 101 77 50 40
GLYBURIDE 100 98 R 51 63
COMBIVENT 98 77 52 107
LOSARTAN POTASSIUM 95 91 53 16
LEVOFLOXACIN 94 86 54 117
QUETIAPINE FUMARATE 91 91 55 69
ROPINIROLE HCL 88 77 56 96
TRIAMTERENE-HCTZ 85 82 57 33
TRIAMCINOLONE ACETONIDE 83 79 58 105
AZITHROMYCIN 83 77 58 70
FLUOXETINE HCL 82 82 60 48
GEMFIBROZIL 82 81 60 72
DIVALPROEX SODIUM 80 74 62 85
GALANTAMINE HBR 79 79 63 219
CARBAMAZEPINE 79 66 63 164
FINASTERIDE 79 79 63 83
TRAZODONE HCL 77 77 66 45
MONOJECT INSULIN SYRINGE 75 75 67 313
CIPROFLOXACIN HCL 74 71 68 90
OXYBUTYNIN CHLORIDE 74 74 68 94
ADVAIR DISKUS 73 50 70 31
CEPHALEXIN 68 65 71 163
DIOVAN 68 62 71 38
OXYCODONE HCL 67 62 S2 73 50
GLIMEPIRIDE 66 46 74 47
NIASPAN 65 58 75 76
METOLAZONE 64 61 76 133
PAROXETINE HCL 62 62 77 64
HUMULIN N 62 62 77 296
ESCITALOPRAM OXALATE 61 61 79 98
AGGRENOX 60 58 80 186
VENLAFAXINE HCL ER 59 59 81 84
AMIODARONE HCL 59 59 81 173
PROAIR HFA 57 32 83 56
AVODART 57 51 83 226
NEXIUM 57 49 83 53
MEGESTROL ACETATE 56 56 R 86 290
DOXYCYCLINE HYCLATE 54 52 87 165
FELODIPINE ER 54 54 87 234
CRESTOR 53 53 89 28
NOVOLOG 53 49 89 93
BENICAR 52 48 91 199
RANITIDINE HCL 52 52 91 42
OXYBUTYNIN CHLORIDE ER 52 38 91 102
SEROQUEL 50 50 94 142
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 19, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.